『The Lancet Respiratory Medicine in conversation with』のカバーアート

The Lancet Respiratory Medicine in conversation with

The Lancet Respiratory Medicine in conversation with

著者： The Lancet Group
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COVID outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.© 2026 The Lancet Group 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn on a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability

    Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn on a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability
    2026/03/26

    Anne-Marie Dingemans, Isabelle Opiz, and Corinne Faivre-Finn talk about their multidisciplinary efforts to develop a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability.

    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00051-2/fulltext

    Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
    続きを読む 一部表示
    28 分
  • Anne Holland and Christine McDonald

    Anne Holland and Christine McDonald
    2026/03/02

    Anne Holland and Christine McDonald join Diana Stanley to discuss ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis.

    Click here to read the full article, Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a randomised sham-controlled trial

    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00005-6/fulltext

    Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
    続きを読む 一部表示
    12 分
  • Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest

    Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest
    2025/12/22

    Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury for the prediction of functional outcome in patients after cardiac arrest using assays that can be analysed on clinically available equipment.

    Click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00363-7/fulltext

    Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
    続きを読む 一部表示
    8 分
adbl_web_anon_alc_button_suppression_c
まだレビューはありません